What do systematic reviews say?

Sclerotherapy vs sclerotherapy with different substances

The review found no eligible studies for this question.

• Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Foam sclerotherapy vs foam sclerotherapy

The review found no eligible studies for this question.

• Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Foam sclerotherapy vs liquid sclerotherapy

The review found no eligible studies for this question.

• Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

PAP therapy vs usual care

• Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 1617 participants
  Low
• Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure 2019 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 1458 participants
  Low

Exercise therapy vs adaptive pacing therapy

The review found no eligible studies for this question.

• Exercise therapy for chronic fatigue syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Systemic therapy vs control

• Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1 participants
  Low

Combination therapy vs anticholinergics

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 56 participants
  Low

Combination therapy vs placebo

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 991 participants
  Very low

Combination therapy vs alpha‐blocker

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  15 studies · 2687 participants
  Very low

Chemmotherapy combined with biological therapy vs chemotherapy alone

Chemmotherapy combined with biological therapy showed no clear difference in quality of life (QoL) compared with chemotherapy (low certainty).

• Salvage systemic therapy for advanced gastric and oesophago‐gastric junction adenocarcinoma 2020 · Cochrane Headline outcomes only
  HR 0.88 [0.74, 1.04]
  2 studies · 1154 participants
  Low

Neoadjuvant chemotherapy prior to interval surgery (NACT) vs surgery followed by chemotherapy (PDS)

• Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 524 participants
  Very low

Chemotherapy with TKI vs chemotherapy alone

Chemotherapy with TKI showed no clear difference in quality of life (QoL) compared with chemotherapy alone (low certainty).

• Angiogenesis inhibitors for the treatment of epithelial ovarian cancer 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 164 participants
  Low

Exercise therapy vs psychological treatment

The review found no eligible studies for this question.

• Exercise therapy for chronic fatigue syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
• Exercise therapy for chronic fatigue syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 44 participants
  Very low

Summary of findings: Molecular‐targeted therapy plus chemotherapy vs chemotherapy alone

• Molecular‐targeted first‐line therapy for advanced gastric cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 53 participants
  Very low

Exercise therapy vs control

The review found no eligible studies for this question.

• Exercise therapy for chronic fatigue syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
• Exercise therapy for chronic fatigue syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 44 participants
  Very low

Exercise therapy vs antidepressants

The review found no eligible studies for this question.

• Exercise therapy for chronic fatigue syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Biological therapy vs placebo, best supportive care (BSC) or no treatment

• Salvage systemic therapy for advanced gastric and oesophago‐gastric junction adenocarcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 283 participants
  Low

Hormonal therapy vs placebo or no intervention

• Hormone therapy for sexual function in perimenopausal and postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 272 participants
  Very low
• Hormone therapy for sexual function in perimenopausal and postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 608 participants
  Moderate

Hormonal therapy vs placebo or no intervention

• Hormone therapy for sexual function in perimenopausal and postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 699 participants
  Moderate

Biofeedback plus standard therapy vs usual care

The review found no eligible studies for this question.

• Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found